Floatz logo

Irbesartan

Essential Hypertension

Hippocration General HospitalSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Essential Hypertension cohort.

Asset / SponsorPhaseRating
Hydrochlorothiazide
Yuhan Corporation
Phase 4BBB
AMLODIPINE
Yuhan Corporation
Phase 4BBB
VALSARTAN
ARKAY Therapeutics
Phase 4BB
LABETALOL
ProMedica Health System
Phase 3BB
Tomato Fruit Extract
Beata Krasinska
Phase 4BB

View all 43 →

Same molecule, other indications

Irbesartan is also rated in:

hypertensive disorderDormant
BB
Indicative ·
70 / 100
View asset →
Abdominal ObesityDormant
BB
Indicative ·
65 / 100
View asset →
chronic hepatitis C virus infectionDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →